Correlation Engine 2.0
Clear Search sequence regions


  • bacillus (1)
  • calcium (5)
  • cancer (1)
  • colon cancer (9)
  • dextran (4)
  • HINT2 (7)
  • humans (1)
  • hydrolases (2)
  • lactobacillus casei (2)
  • MCU (2)
  • mice (2)
  • model experiment (1)
  • prognosis (5)
  • sodium (2)
  • Sizes of these terms reflect their relevance to your search.

    Colorectal cancer (CRC) is one of the most common malignant tumors worldwide. This study aimed to explore the effects of Polysaccharide of Lactobacillus casei SB27 in colon cancer and its possible mechanisms. Colon cancer was induced by giving dextran sulfate sodium and Azoxymethane. Uman Colon Cancer Cell Line (HCT)-116 cells were used to vitro model in this experiment. Polysaccharide of L. casei SB27 reduced colon cancer in azoxymethane-dextran sulfate sodium (AOM+DSS)-induced mice. Polysaccharide of L. casei SB27 reduced colon cancer prognosis in vitro model. Polysaccharide of L. casei SB27 reduced short chain fatty acids by Bacillus coli. Polysaccharide of L. casei promoted mitochondrial damage by Calcium ion entry. Polysaccharide of L. casei induced histidine nucleotide binding protein 2/mitochondrial calcium uniporter (HINT2/MCU) signaling pathway. Immunocoprecipitation (IP) showed that HINT2 protein interlinked MCU protein. Polysaccharide of L. casei suppressed HINT2 ubiquitination. The regulation of HINT2 affected the effects of L. casei polysaccharide on colon cancer prognosis and mitochondrial damage by Calcium ion entry in vitro model. In conclusion, the present report demonstrated that polysaccharide of L. casei SB27 reduced colon cancer cell prognosis through mitochondrial damage by upregulation of HINT2. Polysaccharide of L. casei SB27 might be used for colon cancer treatment and could be helpful for personalized treatment. © 2022 John Wiley & Sons Australia, Ltd.

    Citation

    Wei Di, Xin Li, Qiaoyi Yang. Polysaccharide of Lactobacillus casei SB27 reduced colon cancer cell prognosis through mitochondrial damage by upregulation of HINT2. Asia-Pacific journal of clinical oncology. 2023 Oct;19(5):e248-e257

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36271660

    View Full Text